Idera Pharmaceuticals, Inc. (IDRA) To Be Added To The Russell 3000® And Russell 2000#0174; Indexes
6/27/2014 9:34:49 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical-stage biopharmaceutical company developing nucleotide therapeutics for patients with cancer and orphan diseases, today announced that it will be added to the Russell 3000® and Russell 2000® Indexes when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on Friday, June 27, 2014, according to a preliminary list of additions posted on June 13, 2014 on www.russell.com/indexes.
Help employers find you! Check out all the jobs and post your resume.
comments powered by